MBRS-02. PERSONALIZED IMMUNOTHERAPY WITH TRANSLATABLE RNA NANOPARTICLES TARGETING MEDULLOBLASTOMA

While recurrent medulloblastoma (MB) remains almost uniformly fatal, our group has shown a trend (p=0.07) toward improved survival in patients receiving autologous tumor-RNA pulsed dendritic cells (DCs) coupled with ex vivo expanded total RNA activated T-cells. However, the advancement of autologous...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Sayour, Elias, Mendez-Gomez, Hector, Grippin, Adam, De Leon, Gabriel, Stover, Brian, Flores, Catherine, Pham, Christina, Mitchell, Duane
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012137/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.449
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires